Literature DB >> 25938788

STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection.

Ludovic Desvignes, Carl Weidinger, Patrick Shaw, Martin Vaeth, Theo Ribierre, Menghan Liu, Tawania Fergus, Lina Kozhaya, Lauren McVoy, Derya Unutmaz, Joel D Ernst, Stefan Feske.   

Abstract

Chronic infections induce a complex immune response that controls pathogen replication, but also causes pathology due to sustained inflammation. Ca2+ influx mediates T cell function and immunity to infection, and patients with inherited mutations in the gene encoding the Ca2+ channel ORAI1 or its activator stromal interaction molecule 1 (STIM1) are immunodeficient and prone to chronic infection by various pathogens, including Mycobacterium tuberculosis (Mtb). Here, we demonstrate that STIM1 is required for T cell-mediated immune regulation during chronic Mtb infection. Compared with WT animals, mice with T cell-specific Stim1 deletion died prematurely during the chronic phase of infection and had increased bacterial burdens and severe pulmonary inflammation, with increased myeloid and lymphoid cell infiltration. Although STIM1-deficient T cells exhibited markedly reduced IFN-γ production during the early phase of Mtb infection, bacterial growth was not immediately exacerbated. During the chronic phase, however, STIM1-deficient T cells displayed enhanced IFN-γ production in response to elevated levels of IL-12 and IL-18. The lack of STIM1 in T cells was associated with impaired activation-induced cell death upon repeated TCR engagement and pulmonary lymphocytosis and hyperinflammation in Mtb-infected mice. Chronically Mtb-infected, STIM1-deficient mice had reduced levels of inducible regulatory T cells (iTregs) due to a T cell-intrinsic requirement for STIM1 in iTreg differentiation and excessive production of IFN-γ and IL-12, which suppress iTreg differentiation and maintenance. Thus, STIM1 controls multiple aspects of T cell-mediated immune regulation to limit injurious inflammation during chronic infection.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25938788      PMCID: PMC4518689          DOI: 10.1172/JCI80273

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  88 in total

Review 1.  Immunodeficiency due to defects in store-operated calcium entry.

Authors:  Stefan Feske
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

2.  IL-12 inhibits the TGF-β-dependent T cell developmental programs and skews the TGF-β-induced differentiation into a Th1-like direction.

Authors:  Jana Prochazkova; Katerina Pokorna; Vladimir Holan
Journal:  Immunobiology       Date:  2011-08-05       Impact factor: 3.144

3.  ORAI1 deficiency impairs activated T cell death and enhances T cell survival.

Authors:  Kyun-Do Kim; Sonal Srikanth; Ma-Khin Win Yee; Dennis C Mock; Gregory W Lawson; Yousang Gwack
Journal:  J Immunol       Date:  2011-08-26       Impact factor: 5.422

4.  CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition.

Authors:  Daniel L Barber; Katrin D Mayer-Barber; Carl G Feng; Arlene H Sharpe; Alan Sher
Journal:  J Immunol       Date:  2010-12-20       Impact factor: 5.422

Review 5.  CRAC channelopathies.

Authors:  Stefan Feske
Journal:  Pflugers Arch       Date:  2010-01-29       Impact factor: 3.657

6.  Store-operated Ca2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection.

Authors:  Christie-Ann McCarl; Sara Khalil; Jian Ma; Masatsugu Oh-hora; Megumi Yamashita; Jens Roether; Takumi Kawasaki; Amit Jairaman; Yoshiteru Sasaki; Murali Prakriya; Stefan Feske
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

7.  NFATc1 regulation of TRAIL expression in human intestinal cells.

Authors:  Qingding Wang; Yuning Zhou; Heidi L Weiss; Chi-Wing Chow; B Mark Evers
Journal:  PLoS One       Date:  2011-05-16       Impact factor: 3.240

8.  Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma.

Authors:  Minji Byun; Avinash Abhyankar; Virginie Lelarge; Sabine Plancoulaine; Ayse Palanduz; Leyla Telhan; Bertrand Boisson; Capucine Picard; Scott Dewell; Connie Zhao; Emmanuelle Jouanguy; Stefan Feske; Laurent Abel; Jean-Laurent Casanova
Journal:  J Exp Med       Date:  2010-09-27       Impact factor: 14.307

9.  Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6+ human memory T cells.

Authors:  Qi Wan; Lina Kozhaya; Aimee ElHed; Radha Ramesh; Thaddeus J Carlson; Ivana M Djuretic; Mark S Sundrud; Derya Unutmaz
Journal:  J Exp Med       Date:  2011-08-08       Impact factor: 14.307

10.  Suboptimal activation of antigen-specific CD4+ effector cells enables persistence of M. tuberculosis in vivo.

Authors:  Tyler D Bold; Niaz Banaei; Andrea J Wolf; Joel D Ernst
Journal:  PLoS Pathog       Date:  2011-05-26       Impact factor: 6.823

View more
  26 in total

1.  The Phagocyte Oxidase Controls Tolerance to Mycobacterium tuberculosis Infection.

Authors:  Andrew J Olive; Clare M Smith; Michael C Kiritsy; Christopher M Sassetti
Journal:  J Immunol       Date:  2018-07-30       Impact factor: 5.422

Review 2.  Diseases caused by mutations in ORAI1 and STIM1.

Authors:  Rodrigo S Lacruz; Stefan Feske
Journal:  Ann N Y Acad Sci       Date:  2015-10-15       Impact factor: 5.691

3.  To B, or not to B: Is calcium the answer?

Authors:  Yin-Hu Wang; Anthony Y Tao; Stefan Feske
Journal:  Cell Calcium       Date:  2020-06-03       Impact factor: 6.817

4.  Ca2+ Signaling but Not Store-Operated Ca2+ Entry Is Required for the Function of Macrophages and Dendritic Cells.

Authors:  Martin Vaeth; Isabelle Zee; Axel R Concepcion; Mate Maus; Patrick Shaw; Cynthia Portal-Celhay; Aleena Zahra; Lina Kozhaya; Carl Weidinger; Jennifer Philips; Derya Unutmaz; Stefan Feske
Journal:  J Immunol       Date:  2015-06-24       Impact factor: 5.422

5.  Store-Operated Ca2+ Entry Controls Clonal Expansion of T Cells through Metabolic Reprogramming.

Authors:  Martin Vaeth; Mate Maus; Stefan Klein-Hessling; Elizaveta Freinkman; Jun Yang; Miriam Eckstein; Scott Cameron; Stuart E Turvey; Edgar Serfling; Friederike Berberich-Siebelt; Richard Possemato; Stefan Feske
Journal:  Immunity       Date:  2017-10-11       Impact factor: 31.745

6.  STIM1 and STIM2 cooperatively regulate mouse neutrophil store-operated calcium entry and cytokine production.

Authors:  Regina A Clemens; Joshua Chong; Derayvia Grimes; Yongmei Hu; Clifford A Lowell
Journal:  Blood       Date:  2017-07-19       Impact factor: 22.113

7.  ORAI1 mutations abolishing store-operated Ca2+ entry cause anhidrotic ectodermal dysplasia with immunodeficiency.

Authors:  Jayson Lian; Mario Cuk; Sascha Kahlfuss; Lina Kozhaya; Martin Vaeth; Frédéric Rieux-Laucat; Capucine Picard; Melina J Benson; Antonia Jakovcevic; Karmen Bilic; Iva Martinac; Peter Stathopulos; Imre Kacskovics; Thomas Vraetz; Carsten Speckmann; Stephan Ehl; Thomas Issekutz; Derya Unutmaz; Stefan Feske
Journal:  J Allergy Clin Immunol       Date:  2017-11-16       Impact factor: 10.793

8.  Selective ORAI1 Inhibition Ameliorates Autoimmune Central Nervous System Inflammation by Suppressing Effector but Not Regulatory T Cell Function.

Authors:  Ulrike Kaufmann; Patrick J Shaw; Lina Kozhaya; Raju Subramanian; Kevin Gaida; Derya Unutmaz; Helen J McBride; Stefan Feske
Journal:  J Immunol       Date:  2015-12-16       Impact factor: 5.422

9.  Tuberculosis endotypes to guide stratified host-directed therapy.

Authors:  Andrew R DiNardo; Tomoki Nishiguchi; Sandra L Grimm; Larry S Schlesinger; Edward A Graviss; Jeffrey D Cirillo; Cristian Coarfa; Anna M Mandalakas; Jan Heyckendorf; Stefan H E Kaufmann; Christoph Lange; Mihai G Netea; Reinout Van Crevel
Journal:  Med (N Y)       Date:  2021-01-16

Review 10.  Immunological Disorders: Regulation of Ca2+ Signaling in T Lymphocytes.

Authors:  Sonal Srikanth; Jin Seok Woo; Zuoming Sun; Yousang Gwack
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.